Activated protein C and retinal vein occlusion.

This publication has 11 references indexed in Scilit:

• Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
  1995
• The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
  New England Journal of Medicine, 1995
• Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
  Journal of Clinical Investigation, 1994
• Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
  The Lancet, 1994
• High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis
  British Journal of Haematology, 1994
• Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.
  Journal of Clinical Investigation, 1994
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
  Proceedings of the National Academy of Sciences, 1993
• Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication.
  Proceedings of the National Academy of Sciences, 1993
• Deficiencies of Coagulation-Inhibiting and Fibrinolytic Proteins in Outpatients with Deep-Vein Thrombosis
  New England Journal of Medicine, 1990